Topics: World Population,
Africa is the only world region projected to have strong population growth for the rest of this century. Between 2020 and 2100, Africa’s population is expected to increase from 1.3 billion to 4.3 billion. - Pew Research Center
-
(2)
-
Bookmark
- Comments (0)
Topics: World Population,
Africa is the only world region projected to have strong population growth for the rest of this century. Between 2020 and 2100, Africa’s population is expected to increase from 1.3 billion to 4.3 billion. - Pew Research Center
-
(2)
-
Bookmark
- Comments (0)
Topics: World Population,
Africa is the only world region projected to have strong population growth for the rest of this century. Between 2020 and 2100, Africa’s population is expected to increase from 1.3 billion to 4.3 billion. - Pew Research Center
-
(2)
-
Bookmark
- Comments (0)
Topics: World Population,
Africa is the only world region projected to have strong population growth for the rest of this century. Between 2020 and 2100, Africa’s population is expected to increase from 1.3 billion to 4.3 billion. - Pew Research Center
-
(2)
-
Bookmark
- Comments (0)
07/08/2019 SOURCE: www.fiercebiotech.com
Arming the immune system so it can recognize and attack solid tumors has proven to be an illusive goal. Scientists at Columbia University hope to change that with an engineered form of the bacterium EEngineered bacteria prime solid tumors for immunotherapy
-
(0)
-
Bookmark
- Comments (0)
07/08/2019 SOURCE: www.fiercebiotech.com
Pfizer and Sangamo Therapeutics have shared an upbeat update on their hemophilia A gene therapy. The update features evidence of the durability of responses to SB-525 and an early look at results in two recently-treated patients, adding to the impression that the gene therapy is a threat to assets including BioMarin’s valrox and Spark Therapeutics’ SPK-8011New data boost Pfizer, Sangamo hemophilia A gene therapy
-
(0)
-
Bookmark
- Comments (0)
07/08/2019 SOURCE: www.fiercebiotech.com
Two months after Merck announced a billion-dollar plus deal to buy out late-stage cancer biotech Peloton, some of its staffers are finding new homes. Skyhawk Therapeutics nabs Peloton exec and cancer R&D veteran as VP of oncology biology
-
(0)
-
Bookmark
- Comments (0)
Topics: Pesticides, Beekeeping, Pest Control, Government / Policies,
-
(1)
-
Bookmark
- Comments (0)
-
(1)
-
Bookmark
- Comments (0)